Fundamental Research Division
The DRF at the CEA assemble approximately 6,000 scientists since January 2016.
Découvertes et avancées | Scientific result | Micro-nanotechnologies | Diagnosis and innovative treatment | Medical imaging | MRI | Nanomedicine
BIAM researchers, together with international partners, have succeeded in developing a contrast agent that improves the accuracy of medical imaging, and that is also capable of treating tumors and delivering localized treatment.
Magnetic nanoparticles, in particular iron oxide particles, are employed in medicine for a number of applications including drug delivery and hyperthermia, and can be used as contrast agents in magnetic resonance imaging (MRI). The researchers of the BIAM have developed a hybrid system based on magnetite nanoparticles and the polypeptide polyarginine (polyR-Fe3O4). The particles exhibit low toxicity, comparable to that of Resovist®, a contrast agent commonly used for MRI.
The studies conducted on the use of polyR-Fe3O4 in MRI have shown that the image resolution obtained is 1.6 times higher than with currently used agents.
These hybrid nanoparticles can also be used to locally generate hyperthermia, for example for tumor therapy, with a specific heating power of 208 watts per gram for the hybrids as compared to 83 watts per gram for Feridex®, another agent used in this type of treatment.
Finally, therapeutic molecules were grafted onto the polyR-Fe3O4 surface, and then transported in the body. Polyarginines in particular have the capacity to cross cell membranes, thereby offering additional development opportunities.
The polyR-Fe3O4 hybrid nanoparticles thus possess multiple talents: they can be used as contrast agent for MRI, as therapeutic agent for hyperthermia and as a delivery vector in targeted areas of a cell or a tumor. These properties make polyR-Fe3O4 a theranostic agent (a contraction of the words 'therapy' and 'diagnostic') and a prime candidate for Magnetic Particle Imaging, which is still in development but offers instantaneous images of soft tissues with the highest possible resolution.
CEA is a French government-funded technological research organisation in four main areas: low-carbon energies, defense and security, information technologies and health technologies. A prominent player in the European Research Area, it is involved in setting up collaborative projects with many partners around the world.